ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Semiconducting Polymer Nanoparticles Enable Light-Controlled Bidirectional Modulation of Nitric Oxide in Endothelial Cells.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Endothelial-derived nitric oxide (·NO) is a key signaling molecule in the vascular system, exerting concentration-dependent control over critical cellular functions such as angiogenesis, vascular tone, and endothelial barrier integrity. Tools for achieving reversible, spatiotemporally resolved modulation of intracellular ·NO, without pharmacological or genetic manipulation, are currently lacking. Here, we present a light-activated, nanoparticle (NP)-based strategy enabling bidirectional control of endogenous ·NO in endothelial cells. Composite NPs, based on poly(3-hexylthiophene), P3HT, and poly(3,4-ethylene-dioxythiophene):poly(styrenesulfonate), PEDOT:PSS polymers, are efficiently internalized in human (HUVEC) and murine (H5V) endothelial cells. In dark, NP uptake induces a ROS-dependent, intracellular ·NO increase (+50% and +100% in HUVEC and H5V, respectively, vs. controls), a metabolic shift toward glycolysis and upregulation of both endothelial nitric oxide synthase (eNOS, +50%) and induced nitric oxide synthase (iNOS, +40%). NP photostimulation reverses this response, decreasing ·NO below basal levels, up to -40% in HUVEC and H5V, via ROS-mediated scavenging and iNOS downregulation (-40%), partially restoring oxidative phosphorylation metabolism. Importantly, the photoexcitation protocol is compatible with perspective in vivo use, in terms of source type (LEDs) and power density (6 mW/cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.